Rakvere Tervisemaja OÜ

11481126

General info

Name

Rakvere Tervisemaja OÜ

Registry code

11481126

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

02.04.2008 (16)

Financial year

01.01-31.12

Capital

2 559.00 €

Activity

6820 - Rental and operating of own or leased real estate

Revenue

168 793 €

Profit

23 517 €

Profit margin

14%

Gross salary

238 €

(estimate is approximate)

Equity

26 114 €

Employees

1

Annual report

Submitted

Tax arrears

No tax arrears

Return on equity

90%

Return on assets

5%

Related parties

Owner Representative Beneficial owner Roles

Kodamuse OÜ

12654675

50% - 1 280.00 EUR - -

Marti Kuusik

04.07.1970 (54)

50% - 1 279.00 EUR Board member Direct ownership Founder

Ivo Kuusalu

04.04.1979 (45)

- Board member Member of a higher management body, i.e. board member or supervisory board member

Kersti Kuusalu

25.11.1981 (42)

- - Indirect ownership

Margus Kala

01.02.1972 (52)

- - - Founder

Villu Kuusik

21.08.1979 (45)

- - - Founder

Financial info

2019
26.05.2021
2020
29.09.2021
2021
30.06.2022
2022
01.06.2023
2023
12.06.2024
Total Revenue 0 € 0 € 13 223 € 139 222 € 168 793 €
Net profit (loss) for the period 0 € 0 € -4 433 € 4 471 € 23 517 €
Profit Margin - - -34% 3% 14%
Current Assets 2 556 € 2 556 € 17 418 € 20 289 € 44 687 €
Fixed Assets - - 434 399 € 425 745 € 417 092 €
Total Assets 2 556 € 2 556 € 451 817 € 446 034 € 461 779 €
Current Liabilities - - 25 277 € 24 705 € 24 790 €
Non Current Liabilities - - 428 414 € 418 732 € 410 875 €
Total Liabilities - - 453 691 € 443 437 € 435 665 €
Share Capital - - - - -
Equity 2 556 € 2 556 € -1 874 € 2 597 € 26 114 €
Employees 0 0 1 1 1

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 - 449.1 € 469.56 € 1
2023 Q4 - 353.5 € 369.6 € 1
2023 Q3 - 268.01 € 280.22 € 1
2023 Q2 - 401.69 € 419.99 € 1
2023 Q1 - 464.89 € 436.51 € 1
2022 Q4 - 335.84 € 351.14 € 2
2022 Q3 - 256.82 € 268.52 € 2
2022 Q2 - 366.45 € 381.53 € 2
2022 Q1 - 474.86 € 443.14 € 2
2021 Q4 - - - 2